SPG11 and hereditary spastic paraplegia: The observed increase in peripheral inflammation in the present SPG11–HSP patient cohort is comparable to other neurodegenerative diseases, where the contribution of inflammation is well-established, supporting our findings of neuroinflammatory disease signatures in the limited postmortem tissue.